Reshaping cytoskeleton: different acts of modulatory compounds

Abstract

The eukaryotic cytoskeleton is composed of filamentous structures, namely microfilaments, microtubules and intermediate filaments. The cytoskeleton is an essential component of cells due to its role in various cellular functions, such as intracellular transport, organelle positioning, chromosome segregation and cytokinesis. Abnormalities in cytoskeleton, as well as associated proteins and regulatory pathways, have been shown to contribute to disease pathomechanisms including cancer and neurodegenerative diseases. Therefore, cytoskeleton is an important therapeutic target and many compounds have been identified or developed to modulate the cytoskeleton. In this review, we focused on cytoskeleton modulatory compounds and summarized their mechanisms of action.

Keywords

• Microtubule
• actin
• cytoskeleton modulatory compounds

References

1. • Amin, E., Dubey, B. N., Zhang, S. C., Gremer, L., Dvorsky, R., Moll, J. M., ... & Ahmadian, M. R. (2013). Rho-kinase: regulation, (dys) function, and inhibition. Biological Chemistry, 394(11): 1399–1410. doi:10.1515/hsz-2013-0181.
2. • Bora, G., Sucularlı, C., Hensel, N., Claus, P., & Yurter, H. E. (2019). Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy. The Journal of Pediatric Research, 6(2), 148–154. doi: 10.4274/jpr.galenos.2019.71473
3. • Bora, G., Koyunoğlu, D., Sunguroğlu, M., & Yurter, H. E. (2019). Microtubule Structure, Organization and Defects: Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. Turkiye Klinikleri Journal of Medical Sciences, 39(2), 221–230. doi: 10.5336/medsci. 2018-63881
4. • Brown, S. S., & Spudich, J. A. (1979). Nucleation of polar actin filament assembly by a positively charged surface. The Journal of Cell Biology, 80, 499-504. doi: 10.1083/jcb.80.2.499 • Brown, S. S., & Spudich, J. A. (1981). Mechanism of action of cytochalasin: evidence that it binds to actin filament ends. The Journal of Cell Biology, 88(3), 487–491. doi: 10.1083/jcb.88.3.487
5. • Brunden, K. R., Yao, Y., Potuzak, J. S., Ferrer, N. I., Ballatore, C., James, M. J., …Lee, V. M. Y. (2011). The characterization of microtubulestabilizing drugs as possible therapeutic agents for Alzheimer’s disease and related tauopathies. Pharmacological Research, 63(4), 341–351. https://doi.org/10.1016/j.phrs.2010.12.002
6. • Bryce, N. S., Hardeman, E. C., Gunning, P. W., & Lock, J. G. (2019). Chemical biology approaches targeting the actin cytoskeleton through phenotypic screening. Current Opinion in Chemical Biology, 51, 40–47. doi: 10.1016/j.cbpa.2019.02.013
7. • Carlier, M. F. (2001). Faculty of 1000 evaluation for A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. F1000 - Post-Publication Peer Review of the Biomedical Literature. doi: 10.3410/f.1000267.14705
8. • Chen, Y., & Hancock, W. O. (2015). Kinesin-5 is a microtubule polymerase. Nature Communications, 6(1). doi: 10.1038/ncomms9160 • Colchicine for Amyotrophic Lateral Sclerosis - Full Text View. (n.d.). Retrieved from https://clinicaltrials.gov/ct2/show/NCT03693781

9. • Coluccio, L. M., & Tilney, L. G. (1984). Phalloidin enhances actin assembly by preventing monomer dissociation. Journal of Cell Biology, 99(2), 529–535. https://doi.org/10.1083/jcb.99.2.529
10. • Currier, M. A., Stehn, J. R., Swain, A., Chen, D., Hook, J., Eiffe, E., … Cripe, T. P. (2017). Identification of Cancer-Targeted Tropomyosin Inhibitors and Their Synergy with Microtubule Drugs. Molecular Cancer Therapeutics, 16(8), 1555–1565. doi: 10.1158/1535-7163. mct-16-0873
11. • Dalbeth, N., Lauterio, T. J., & Wolfe, H. R. (2014). Mechanism of action of colchicine in the treatment of gout. Clinical Therapeutics, 36(10), 1465–1479. https://doi.org/10.1016/j.clinthera.2014.07.017
12. • Dubey, J., Ratnakaran, N., & Koushika, S. P. (2015). Neurodegeneration and microtubule dynamics: Death by a thousand cuts. Frontiers in Cellular Neuroscience, 9(September), 1–15. https://doi. org/10.3389/fncel.2015.00343
13. • Engel, T., Goñi-Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006). (Engel et al., 2006) pre-formed neurofibrillary tangles do not revert. Journal of Neurochemistry, 99(6), 1445–1455. https://doi. org/10.1111/j.1471-4159.2006.04139.x
14. • Evans, K. J., Gomes, E. R., Reisenweber, S. M., Gundersen, G. G., & Lauring, B. P. (2005). Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. Journal of Cell Biology 168, 599–606. https://doi.org/10.1083/jcb.200409058
15. • Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., … Brábek, J. (2017). Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges. Trends in Cancer, 3(6), 391–406. https://doi.org/10.1016/j.trecan.2017.04.008
16. • Grin, B., Mahammad, S., Wedig, T., Cleland, M. M., Tsai, L., Herrmann, H., & Goldman, R. D. (2012). Withaferin A alters intermediate filament organization, cell shape and behavior. PLoS ONE, 7(6), 1–13. https://doi.org/10.1371/journal.pone.0039065
17. • Guo, W., Naujock, M., Fumagalli, L., Vandoorne, T., Baatsen, P., Boon, R., … Van Den Bosch, L. (2017). HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUSALS patients. Nature Communications, 8(1), 1–14. https://doi. org/10.1038/s41467-017-00911-y.
18. • Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., … Weissenbach, J. (1999). Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nature Genetics, 23(3), 296–303. doi: 10.1038/15472
19. • Janke, C., & Kneussel, M. (2010). Tubulin post-translational modifications: Encoding functions on the neuronal microtubule cytoskeleton. Trends in Neurosciences, 33(8), 362–372. https://doi. org/10.1016/j.tins.2010.05.001
20. • Lee, J. J., & Swain, S. M. (2008). The epothilones: Translating from the laboratory to the clinic. Clinical Cancer Research, 14(6), 1618– 1624. https://doi.org/10.1158/1078-0432.CCR-07-2201
21. • Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011). GSK-3 in neurodegenerative diseases. International Journal of Alzheimer’s Disease, 2011. https://doi.org/10.4061/2011/189246
22. • Lodish, H., Berk, A., Matsudaira, P., Kaiser, C. A., Krieger, M., Scott, M. P., Zipursky, S. L., & Darnell, J. (2003). Molecular Cell Biology. New York: W. H. Freeman.
23. • Nakashima, S., Matsuda, H., Kurume, A., Oda, Y., Nakamura, S., Yamashita, M., & Yoshikawa, M. (2010). Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. Bioorganic and Medicinal Chemistry Letters, 20(9), 2994–2997. https://doi.org/10.1016/j.bmcl.2010.02.062
24. • Niel, E., & Scherrmann, J. M. (2006). Colchicine today. Joint Bone Spine, 73(6), 672–678. https://doi.org/10.1016/j.jbspin.2006.03.006
25. • Overmoyer, B., Waintraub, S., Kaufman, P. A., Doyle, T., Moore, H., Modiano, M., … Demario, M. (2005). Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer. Journal of Clinical Oncology, 23(16_suppl), 778–778. doi: 10.1200/jco.2005.23.16_suppl.778
26. • Palazzo, A., Ackerman, B., & Gundersen, G. G. (2003). Tubulin acetylation and cell motility. Nature, 421(6920), 230. https://doi. org/10.1038/421230a
27. • Peterson, J. R., & Mitchison, T. J. (2002). Small molecules, big impact: A history of chemical inhibitors and the cytoskeleton. Chemistry and Biology, 9(12), 1275–1285. https://doi.org/10.1016/ S1074-5521(02)00284-3
28. • Roossien, D. H., Miller, K. E., & Gallo, G. (2015). Ciliobrevins as tools for studying dynein motor function. Frontiers in Cellular Neuroscience, 9(JULY), 1–10. https://doi.org/10.3389/fncel.2015.00252
29. • Sánchez, C., Pérez, M., & Avila, J. (2000). GSK3β-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. European Journal of Cell Biology, 79(4), 252–260. https://doi.org/10.1078/S0171-9335(04)70028-X
30. • Schofield, A. V., Steels, R., & Bernard, O. (2012). Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration. Journal of Biological Chemistry, 287(52), 43620–43629. https://doi. org/10.1074/jbc.M112.394965
31. • Selenica, M. L., Jensen, H. S., Larsen, A. K., Pedersen, M. L., Helboe, L., Leist, M., & Lotharius, J. (2007). Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. British Journal of Pharmacology, 152(6), 959–979. doi: 10.1038/sj.bjp.0707471
32. • Steinmetz, M. O., & Prota, A. E. (2018). Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton. Trends in Cell Biology, 28(10), 776–792. https://doi.org/10.1016/j.tcb.2018.05.001
33. • Trivedi, N., Marsh, P., Goold, R. G., Wood-Kaczmar, A., & Gordon- Weeks, P. R. (2005). Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons. Journal of Cell Science, 118(5), 993–1005. https:// doi.org/10.1242/jcs.01697
34. • Trogden, K. P., Battaglia, R. A., Kabiraj, P., Madden, V. J., Herrmann, H., & Snider, N. T. (2018). An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells. Federation of American Societies for Experimental Biology Journal, 32(5), 2841–2854. https://doi.org/10.1096/fj.201700663R
35. • Xu, W., Ge, Y., Liu, Z., & Gong, R. (2015). Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion. Journal of Biological Chemistry, 290(3), 1348–1363. https://doi.org/10.1074/jbc.M114.593830
36. • Yee, L., Lynch, T., Villalona-Calero, M., Rizvi, N., Gabrail, N., Sandler, A., … Palmer, G. (2005). A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer. Journal of Clinical Oncology, 23(16_suppl), 7127–7127. doi: 10.1200/ jco.2005.23.16_suppl.7127
37. • Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., & Kaibuchi, K. (2005). GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell, 120(1), 137–149. https://doi. org/10.1016/j.cell.2004.11.012
38. • Zemer, D., Pras, M., Sohar, E., Modan, M., Cabili, S., & Gafni, J. (1986). Colchicine in the prevention and treatment of the amyloidosis of Familial Mediterranean fever. The New England Journal of Medicine, 314, 1001-1005. doi:10.1056/NEJM198604173141601
39. • Zhang, B., Carroll, J., Trojanowski, J. Q., Yao, Y., Iba, M., Potuzak, J. S., … Brunden, K. R. (2012). The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice. Journal of Neuroscience, 32(11), 3601–3611. doi: 10.1523/jneurosci.4922-11.2012
40. • Zigmond, S. H. (2000). How Wasp Regulates Actin Polymerization. The Journal of Cell Biology, 150(6). doi: 10.1083/jcb.150.6.f117
41. • Zumbrunn, J., Kinoshita, K., Hyman, A. A., & Näthke, I. S. (2001). Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation. Current Biology, 11(1), 44–49. doi: 10.1016/s0960-9822(01)00002-1.